Drug Enforcement D-0513-2024

Lack of Assurance of Sterility

Status

Ongoing

Classification

Class II

Report Date

June 5, 2024

Termination Date

Product Information

Product description
Dexamethasone-Moxifloxacin (1 mg/mL and 5mg/mL) Preservative-Free, 1mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-512-01
Product quantity
39,700 vials
Reason for recall
Lack of Assurance of Sterility
Recall initiation reason
Initial firm notification
Distribution pattern
Nationwide within the United States

Location & Firm

Recalling firm
Imprimis NJOF, LLC
Address
1705 Route 46 Ste 6B

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0513-2024
Event ID
94551
Recall initiation date
May 14, 2024
Center classification date
May 29, 2024
Code info
Lot #: 23MAY016, Exp. Date 5/8/24; 23JUL016, Exp. Date 7/10/24; 23AUG034, Exp. Date 8/16/24; 23DEC014, Exp. Date 12/10/24
More code info